Floatz logo

Keppra

Mental Retardation

Oslo University HospitalPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Mental Retardation cohort.

Asset / SponsorPhaseRating
LAMOTRIGINE
Oslo University Hospital
Phase 4BB
Topamax
Oslo University Hospital
Phase 4BB
Felbamate
Oslo University Hospital
Phase 4BB
Carbamazepine
Oslo University Hospital
Phase 4BB
Tiagabine
Oslo University Hospital
Phase 4BB

View all 16 →

Same molecule, other indications

Keppra is also rated in:

Epilepsy, PartialDormant
A
Indicative ·
80 / 100
View asset →
Epilepsy, Tonic-clonicDormant
BBB
Indicative ·
78 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →